Shared Resource 16: Research Pharmacy

共享资源 16：研究药房

• 批准号: 10062911
• 负责人: Sylvia Bartel
• 金额: $ 21.8万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-03-10 至 2021-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10062911
• 关键词: Boston; Cancer Center; Cancer Center Support Grant; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Complement; Comprehensive Cancer Center; Consultations; Dana-Farber Cancer Institute; Data; Development; Education; Elements; Ensure; Equipment and supply inventories; Formulation; Fostering; Funding; General Hospitals; Guidelines; Hospitals; Institution; Investigation; Investigational Drugs; Israel; Location; Malignant Neoplasms; Massachusetts; Medical center; Monitor; Monitoring Clinical Trials; Oral; Pediatric Hospitals; Performance; Pharmaceutical Preparations; Pharmacists; Pharmacy facility; Policies; Procedures; Protocols documentation; Regulation; Reporting; Research; Research Personnel; Research Support; Resource Sharing; Resources; Review Committee; Safety; Self Administration; Serious Adverse Event; Site; System; Teacher Professional Development; Training; Training and Education; Update; Woman; Work; base; design; inter-institutional; meetings; member; programs; quality assurance; service member

Research Pharmacy Shared Resource Project Summary / Abstract The Research Pharmacy Core has a well-developed system for the monitoring, coordination, and support of research pharmacy activities at DF/HCC member institutions. The Core assures consistency in policies across the sites (including policies relating to the receipt, storage, formulation, and dispensation of investigational agents), facilitates best practices, and monitors performance through a quality assurance program coordinated through the inter-institutional Research Pharmacy Core Committee. The Research Pharmacy participates in the DF/HCC Protocol Review and Monitoring System (PRMS) Committees and Data and Safety Monitoring (DSM) program, as well as other relevant DF/HCC clinical trials oversight, monitoring, and policy initiatives.

研究药房共享资源 项目摘要 /摘要 研究药房核心具有一个完善的系统，用于监视，协调和支持 DF/HCC成员机构的研究药房活动。核心确保跨政策的一致性 这些站点（包括与收据，存储，配方有关的政策 代理商），促进最佳实践，并通过质量保证计划协调监视性能 通过机构间研究药房核心委员会。研究药房参与 DF/HCC协议审查和监控系统（PRMS）委员会以及数据和安全监控 （DSM）以及其他相关的DF/HCC临床试验监督，监测和政策计划。